Terms: = Gastric cancer AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4 AND Treatment
26 results:
1. Discovery of a novel Coumarin-Dihydroquinoxalone derivative MY-673 as a tubulin polymerization inhibitor capable of inhibiting the ERK pathway with potent anti-gastric cancer activities.
Song J; Wang SY; Wang X; Jia MQ; Tian XY; Fu XJ; Jin CY; Zhang SY
Bioorg Chem; 2023 Aug; 137():106580. PubMed ID: 37149948
[TBL] [Abstract] [Full Text] [Related]
2. Downregulation of TRIM33 Promotes Survival and Epithelial-Mesenchymal Transition in gastric cancer.
Wang F; Wang W; Wu X; Tang C; Du F; Lu Z; Zhang Z; Xu H; Cao X; Li PA
Technol Cancer Res Treat; 2022; 21():15330338221114505. PubMed ID: 35929141
[TBL] [Abstract] [Full Text] [Related]
3. Flavokawain B Weakens gastric cancer Progression via the TGF-
Zhu Y; Fan W; Wang Y; Ding H; Yang S; He F
J Immunol Res; 2022; 2022():4903333. PubMed ID: 35879950
[TBL] [Abstract] [Full Text] [Related]
4. Association of recurrent APOBEC3B alterations with the prognosis of gastric-type cervical adenocarcinoma.
Liao X; Xia X; Su W; Yan H; Ma Y; Xu L; Luo H; Liu W; Yin D; Zhang WH; Chen HN; Deng Y; Ren Z; Yu Z; Liao F; Chen K; Cao M; Zhang Y; Zhang W; Wang W; Zhao JN; Xu H; Shu Y
Gynecol Oncol; 2022 Apr; 165(1):105-113. PubMed ID: 35151492
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic value of small mother against decapentaplegic expression in human gastric cancer.
Zhang HW; Guo Y; Sun LX; Ni FB; Xu K
Bioengineered; 2021 Dec; 12(1):2534-2549. PubMed ID: 34138687
[TBL] [Abstract] [Full Text] [Related]
6. AGAPP: efficacy of first-line cisplatin, 5-fluorouracil with afatinib in inoperable gastric and gastroesophageal junction carcinomas. A Hellenic Cooperative Oncology Group study.
Zarkavelis G; Samantas E; Koliou GA; Papadopoulou K; Mauri D; Aravantinos G; Batistatou A; Pazarli E; Tryfonopoulos D; Tsipoura A; Bobos M; Psyrri A; Makatsoris T; Petraki C; Pectasides D; Fountzilas G; Pentheroudakis G
Acta Oncol; 2021 Jun; 60(6):785-793. PubMed ID: 34003074
[TBL] [Abstract] [Full Text] [Related]
7. Molecular and pathological analyses of gastric stump cancer by next-generation sequencing and immunohistochemistry.
Watanabe M; Kuwata T; Setsuda A; Tokunaga M; Kaito A; Sugita S; Tonouchi A; Kinoshita T; Nagino M
Sci Rep; 2021 Feb; 11(1):4165. PubMed ID: 33603111
[TBL] [Abstract] [Full Text] [Related]
8. Circ_smad4 promotes gastric carcinogenesis by activating wnt/β-catenin pathway.
Wang L; Li B; Yi X; Xiao X; Zheng Q; Ma L
Cell Prolif; 2021 Mar; 54(3):e12981. PubMed ID: 33458917
[TBL] [Abstract] [Full Text] [Related]
9. Cystatin 2 leads to a worse prognosis in patients with gastric cancer.
Zhang WP; Wang Y; Tan D; Xing CG
J Biol Regul Homeost Agents; 2020; 34(6):2059-2067. PubMed ID: 33302616
[TBL] [Abstract] [Full Text] [Related]
10. Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure.
Lin Z; Huang L; Li S; Gu J; Cui X; Zhou Y
Sci Rep; 2020 Dec; 10(1):21530. PubMed ID: 33299035
[TBL] [Abstract] [Full Text] [Related]
11. Piperlongumine induces ROS mediated cell death and synergizes paclitaxel in human intestinal cancer cells.
Rawat L; Hegde H; Hoti SL; Nayak V
Biomed Pharmacother; 2020 Aug; 128():110243. PubMed ID: 32470748
[TBL] [Abstract] [Full Text] [Related]
12. Effects of propofol and sevoflurane on tumor killing activity of peripheral blood natural killer cells in patients with gastric cancer.
Ai L; Wang H
J Int Med Res; 2020 Mar; 48(3):300060520904861. PubMed ID: 32216484
[TBL] [Abstract] [Full Text] [Related]
13. MiR-187 influences cisplatin-resistance of gastric cancer cells through regulating the TGF-β/Smad signaling pathway.
Zhu QL; Li Z; Lv CM; Wang W
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9907-9914. PubMed ID: 31799659
[TBL] [Abstract] [Full Text] [Related]
14. gastric cancer and paraneoplastic dermatomyositis as complications of an unrecognized juvenile polyposis syndrome.
Schiemer M; Schmitt-Graeff A; Brass V; Hasselblatt P
Z Gastroenterol; 2019 Apr; 57(4):497-500. PubMed ID: 30873576
[TBL] [Abstract] [Full Text] [Related]
15. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and gastric Adenocarcinoma.
Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
[TBL] [Abstract] [Full Text] [Related]
16. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote gastric cancer Metastasis by Targeting Timp3.
Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
[TBL] [Abstract] [Full Text] [Related]
17. miR-148a downregulates the expression of transforming growth factor-β2 and SMAD2 in gastric cancer.
Zhang W; Li Y
Int J Oncol; 2016 May; 48(5):1877-85. PubMed ID: 26983401
[TBL] [Abstract] [Full Text] [Related]
18. Stem Cells Antigen-1 Enriches for a cancer Stem Cell-Like Subpopulation in Mouse gastric cancer.
Park JW; Park JM; Park DM; Kim DY; Kim HK
Stem Cells; 2016 May; 34(5):1177-87. PubMed ID: 26869189
[TBL] [Abstract] [Full Text] [Related]
19. Tumor profiling of gastric and esophageal carcinoma reveal different treatment options.
Miura JT; Xiu J; Thomas J; George B; Carron BR; Tsai S; Johnston FM; Turaga KK; Gamblin TC
Cancer Biol Ther; 2015; 16(5):764-9. PubMed ID: 25778705
[TBL] [Abstract] [Full Text] [Related]
20. Baicalein inhibits migration and invasion of gastric cancer cells through suppression of the TGF-β signaling pathway.
Chen F; Zhuang M; Peng J; Wang X; Huang T; Li S; Lin M; Lin H; Xu Y; Li J; Chen Z; Huang Y
Mol Med Rep; 2014 Oct; 10(4):1999-2003. PubMed ID: 25109410
[TBL] [Abstract] [Full Text] [Related]
[Next]
